Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

BACKGROUND. Treatment of splenic marginal zone lymphoma (SMZL) patients is not standardized. Recent data suggest that rituximab is highly effective and could be considered as initial therapy. AIM. To assess the efficacy of rituximab monotherapy in a large series of patients with SMZL and compare the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kalpadakis, Christina, Pangalis, Gerassimos A., Angelopoulou, Maria K., Sachanas, Sotirios, Kontopidou, Flora N., Yiakoumis, Xanthi, Kokoris, Stella I., Dimitriadou, Evagelia M., Dimopoulou, Maria N., Moschogiannis, Maria, Korkolopoulou, Penelope, Kyrtsonis, Marie-Christine, Siakantaris, Marina P., Papadaki, Theodora, Tsaftaridis, Panayiotis, Plata, Eleni, Papadaki, Helen E., Vassilakopoulos, Theodoros P.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2013
Assuntos:
Lymphoma
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579603/
https://ncbi.nlm.nih.gov/pubmed/23345547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0251
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares